Network pharmacology and molecular docking approaches predict the mechanisms of Corididius chinensis in treating manganese-induced nervous system diseases: A review

Mei Zhang,Huixian Lou,Jing Ma,Keyi Xiong,Xiaohui Hou
DOI: https://doi.org/10.1097/md.0000000000035669
IF: 1.6
2024-02-10
Medicine
Abstract:Fast-growing studies shown that neurodegenerative diseases are closely related to environmental transition metal exposure. [ 1–3 ] Recent clinical trials have shown that long-term exposure to manganese (Mn) is associated with a high risk of developing neurodegenerative diseases, such as Parkinson disease (PD). [ 4 , 5 ] Another study also demonstrated that PD model could be constructed reliably when rats inhaled Mn mixture. [ 6 ] At the cellular level, Mn directly causes mitochondrial dysfunction by destroying mitochondrial complex I and consuming mitochondrial ATP storage. Moreover, the stress response in mitochondrion is activated, and ROS are stimulated to produce more toxic reactions and apoptosis. [ 7 ] Clinically, the symptoms of Mn poisoning include depression, anxiety, cognitive impairment and autonomic dysfunction. [ 8 ] Current treatment options for PD are mainly symptomatic because the etiological physiology has not been fully elucidated. Dopamine and other drugs have been shown to be effective in PD. [ 9 ] However, more effective and less toxic medicines are expected to be developed to treat Mn-induced nervous system diseases.
medicine, general & internal
What problem does this paper attempt to address?